News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

John Cannon Named Acting CFO of ConvaTec


7/2/2013 6:51:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LUXEMBOURG, July 1, 2013 /PRNewswire/ -- ConvaTec, a privately-held developer and marketer of innovative medical technologies, today announced that John Cannon has been named acting Chief Financial Officer of the company.

Mr. Cannon succeeds Edward Borkowski, who has left the company.

"I would like to thank Ed for his contributions to ConvaTec's success over the past year and wish him well in the future," said Ken Berger, CEO of ConvaTec.

Mr. Cannon is currently Vice President, Finance, for ConvaTec's global Operations, which includes manufacturing, and for its Asia-Pacific and EMEA regions.

Mr. Cannon previously was with PMC Treasury, a financial advisory firm for private-equity sponsored companies, and was the senior financial officer with Singer Sewing. Earlier, he spent fifteen years in banking with Bankers Trust/Deutsche Bank, including eight years in Asia-Pacific. He has a BS degree in physics and economics from Haverford College and an MBA from New York University's Stern School of Business.

About ConvaTec
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices ConvaTec products support healthcare professionals from the hospital to the community health setting. The company is owned by Nordic Capital and Avista Capital Partners. For more information, please visit www.convatec.com

SOURCE ConvaTec



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
ConvaTec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES